RELIV INTERNATIONAL INC

2020 Q3 Form 10-Q Financial Statement

#000143774920017937 Filed on August 14, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2020 Q2 2019 Q2

Balance Sheet

Concept 2020 Q3 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.340M $2.731M $1.919M
YoY Change 31.44% 42.32% -30.48%
Cash & Equivalents $3.340M $2.731M $1.919M
Short-Term Investments
Other Short-Term Assets $465.4K $605.8K $740.0K
YoY Change -48.43% -18.14% -80.05%
Inventory $2.829M $3.028M $2.709M
Prepaid Expenses
Receivables $58.16K $279.9K $235.0K
Other Receivables $1.131M $1.139M $1.053M
Total Short-Term Assets $7.823M $7.783M $6.656M
YoY Change 8.86% 16.94% -39.21%
LONG-TERM ASSETS
Property, Plant & Equipment $4.208M $4.281M $4.569M
YoY Change -6.78% -6.3% -16.03%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $505.0K $505.0K $505.0K
YoY Change 0.0% 0.0%
Other Assets $407.8K
YoY Change 20.6%
Total Long-Term Assets $8.883M $9.075M $10.15M
YoY Change -7.98% -10.56% 10.46%
TOTAL ASSETS
Total Short-Term Assets $7.823M $7.783M $6.656M
Total Long-Term Assets $8.883M $9.075M $10.15M
Total Assets $16.71M $16.86M $16.80M
YoY Change -0.79% 0.33% -16.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.683M $1.820M $1.918M
YoY Change -27.0% -5.13% -16.6%
Accrued Expenses $1.659M $1.553M $1.484M
YoY Change -7.53% 4.65% 290.63%
Deferred Revenue $309.0K $317.6K $356.9K
YoY Change -10.65% -10.99% 0.23%
Short-Term Debt $500.0K $500.0K $500.0K
YoY Change 0.0% 0.0% 0.0%
Long-Term Debt Due $977.2K $833.6K
YoY Change
Total Short-Term Liabilities $4.674M $4.575M $4.437M
YoY Change -7.53% 3.12% -36.0%
LONG-TERM LIABILITIES
Long-Term Debt $384.8K $528.4K $0.00
YoY Change
Other Long-Term Liabilities $126.3K $140.5K $507.6K
YoY Change 22.74% -72.32% 10.65%
Total Long-Term Liabilities $599.0K $771.1K $626.7K
YoY Change 153.91% 23.04% 36.61%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.674M $4.575M $4.437M
Total Long-Term Liabilities $599.0K $771.1K $626.7K
Total Liabilities $5.273M $5.346M $5.064M
YoY Change -0.33% 5.58% -31.49%
SHAREHOLDERS EQUITY
Retained Earnings -$12.42M -$12.29M -$12.08M
YoY Change 1.43% 1.79% 3.88%
Common Stock $30.65M $30.65M $30.64M
YoY Change 0.02% 0.03% 0.06%
Preferred Stock
YoY Change
Treasury Stock (at cost) $5.851M $5.851M $5.851M
YoY Change 0.0% 0.0% 9.61%
Treasury Stock Shares
Shareholders Equity $11.43M $11.51M $11.74M
YoY Change
Total Liabilities & Shareholders Equity $16.71M $16.86M $16.80M
YoY Change -0.79% 0.33% -16.55%

Cashflow Statement

Concept 2020 Q3 2020 Q2 2019 Q2

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000768710
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1746499
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Registrant Name
EntityRegistrantName
RELIV INTERNATIONAL INC
dei Entity Shell Company
EntityShellCompany
false
dei Entity Small Business
EntitySmallBusiness
true
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001
dei Trading Symbol
TradingSymbol
relv
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
279920
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
107369
CY2020Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
50955
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
121177
CY2020Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
971449
CY2019Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
891492
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10215740
CY2020Q2 relv Accounts Payable And Accrued Liabilities Current Excluding Income Taxes Payable
AccountsPayableAndAccruedLiabilitiesCurrentExcludingIncomeTaxesPayable
3171152
CY2019Q4 relv Accounts Payable And Accrued Liabilities Current Excluding Income Taxes Payable
AccountsPayableAndAccruedLiabilitiesCurrentExcludingIncomeTaxesPayable
2808948
CY2020Q2 relv Computer Equipment And Software Gross
ComputerEquipmentAndSoftwareGross
2202627
CY2019Q4 relv Computer Equipment And Software Gross
ComputerEquipmentAndSoftwareGross
2240063
relv Contract With Customer Returns As Percent Of Net Sales
ContractWithCustomerReturnsAsPercentOfNetSales
0.0005
relv Contract With Customer Returns As Percent Of Net Sales
ContractWithCustomerReturnsAsPercentOfNetSales
0.0007
CY2020Q1 relv Estimated Tax Benefit Nol Carryback
EstimatedTaxBenefitNolCarryback
225000
relv Increase Decrease In Accounts Receivable And Due From Related Parties And Distibutors
IncreaseDecreaseInAccountsReceivableAndDueFromRelatedPartiesAndDistibutors
-30349
relv Increase Decrease In Accounts Receivable And Due From Related Parties And Distibutors
IncreaseDecreaseInAccountsReceivableAndDueFromRelatedPartiesAndDistibutors
715018
CY2020Q2 relv Inventory Sales Aids And Promotional Materials Net Of Reserves
InventorySalesAidsAndPromotionalMaterialsNetOfReserves
97026
CY2019Q4 relv Inventory Sales Aids And Promotional Materials Net Of Reserves
InventorySalesAidsAndPromotionalMaterialsNetOfReserves
120811
CY2019Q1 relv Treasury Stock Value Other
TreasuryStockValueOther
27281
CY2020Q2 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
1819772
CY2019Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
1565198
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10086560
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-990727
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-937320
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
30643771
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
30643771
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5306
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-398563
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
409872
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
247292
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
622725
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
645855
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Concentrations of Risk</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Effective <div style="display: inline; font-style: italic; font: inherit;"> January 1, 2019, </div>we have entered into outsourcing agreements with Nutracom LLC (&#x201c;Nutracom&#x201d;) to manufacture our nutritional and dietary supplements and for warehousing and fulfillment services for the U.S. distribution of our products. Nutracom has also issued promissory notes to us for the acquisition of our manufacturing and fulfillment operations. Any inability of Nutracom to deliver these contracted services or to repay the promissory notes could adversely impact our future operating results and valuation of our Nutracom equity investment. See Note <div style="display: inline; font-style: italic; font: inherit;">2</div> and Note <div style="display: inline; font-style: italic; font: inherit;">3</div> for further discussion of our relationship with Nutracom.</div></div></div></div></div></div></div></div></div></div></div>
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5306
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5000
CY2020Q2 us-gaap Assets
Assets
16858003
CY2019Q4 us-gaap Assets
Assets
15306996
CY2020Q2 us-gaap Assets Current
AssetsCurrent
7783386
CY2019Q4 us-gaap Assets Current
AssetsCurrent
5865518
CY2020Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
10147386
CY2019Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
10145005
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2730672
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1630779
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1630779
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1989974
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2730672
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1918721
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1099893
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-71253
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2110013
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2110013
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1746449
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1746449
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
2110
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
2110
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-212853
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
317630
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
322261
CY2020Q2 us-gaap Cost Method Investments
CostMethodInvestments
505000
CY2019Q4 us-gaap Cost Method Investments
CostMethodInvestments
505000
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2202488
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2268992
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4857331
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4702723
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
8293670
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
8623029
us-gaap Costs And Expenses
CostsAndExpenses
18054650
us-gaap Costs And Expenses
CostsAndExpenses
17913860
CY2020Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1362000
CY2019Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
500000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
288273
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
292842
CY2020Q2 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
889022
CY2019Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
1099228
CY2020Q2 us-gaap Due From Related Parties Noncurrent
DueFromRelatedPartiesNoncurrent
2361910
CY2019Q4 us-gaap Due From Related Parties Noncurrent
DueFromRelatedPartiesNoncurrent
2418921
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.27
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.13
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-30775
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12808
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.365
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.32
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
198747
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
212716
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1609285
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1722277
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-21694
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-1149
CY2020Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
1241860
CY2019Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
1237142
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
434549
CY2020Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
CY2019Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-145057
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-325105
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
339279
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
346539
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
54000
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
63000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-124000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
111000
CY2020Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
249959
CY2019Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
22406
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
402018
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-293111
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-71132
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
16148
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
227553
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
3295
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
380827
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-758798
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
CY2019Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
46218
us-gaap Investment Income Interest
InvestmentIncomeInterest
78710
us-gaap Investment Income Interest
InvestmentIncomeInterest
95480
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
68807
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
304407
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
295925
CY2020Q2 us-gaap Interest Expense
InterestExpense
7933
CY2019Q2 us-gaap Interest Expense
InterestExpense
10075
us-gaap Interest Expense
InterestExpense
14038
us-gaap Interest Expense
InterestExpense
15487
us-gaap Interest Income Related Party
InterestIncomeRelatedParty
76210
us-gaap Interest Income Related Party
InterestIncomeRelatedParty
92668
CY2020Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2816982
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2275306
CY2020Q2 us-gaap Inventory Net
InventoryNet
3028031
CY2019Q4 us-gaap Inventory Net
InventoryNet
2701688
CY2020Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
114023
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
305571
CY2020Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
39048
CY2020Q2 us-gaap Land And Land Improvements
LandAndLandImprovements
905190
CY2019Q4 us-gaap Land And Land Improvements
LandAndLandImprovements
905190
CY2019Q1 us-gaap Lessor Operating Lease Renewal Term
LessorOperatingLeaseRenewalTerm
P5Y
CY2019Q1 us-gaap Lessor Operating Lease Term Of Contract
LessorOperatingLeaseTermOfContract
P7Y
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16858003
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15306996
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4575366
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3989157
CY2020Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
771122
CY2019Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
216196
CY2020Q2 us-gaap Line Of Credit
LineOfCredit
500000
CY2019Q4 us-gaap Line Of Credit
LineOfCredit
500000
CY2020Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
500000
CY2019Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
500000
CY2020Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
833649
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
500000
CY2020Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
528351
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
CY2020Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
528351
CY2019Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
862000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
500000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
46974
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
59804
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
221694
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-643865
us-gaap Net Income Loss
NetIncomeLoss
463279
us-gaap Net Income Loss
NetIncomeLoss
235539
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-199057
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-388105
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
662336
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
623644
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
109984
CY2020Q2 us-gaap Notes Payable Current
NotesPayableCurrent
333649
CY2019Q4 us-gaap Notes Payable Current
NotesPayableCurrent
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
6
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-277110
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-366016
us-gaap Operating Income Loss
OperatingIncomeLoss
244575
us-gaap Operating Income Loss
OperatingIncomeLoss
-167343
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
201980
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
236771
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
102260
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
103580
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
317099
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
354440
CY2020Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-13796
CY2019Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-10458
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-53407
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
11753
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-39611
CY2019Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
22211
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
140511
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
112616
us-gaap Other Noncash Expense
OtherNoncashExpense
us-gaap Other Noncash Expense
OtherNoncashExpense
24618
us-gaap Other Noncash Income
OtherNoncashIncome
us-gaap Other Noncash Income
OtherNoncashIncome
172866
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
100938
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4768
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
30032
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-660
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17363
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
50180
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
605782
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
304048
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
64337
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
862000
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
500000
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14497063
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14527400
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4281323
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4440840
CY2020Q2 us-gaap Purchase Obligation
PurchaseObligation
1270000
us-gaap Related Party Transaction Other Revenues From Transactions With Related Party
RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
374444
us-gaap Related Party Transaction Other Revenues From Transactions With Related Party
RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
332657
us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
316910
us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
305910
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12292216
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12755495
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8016560
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8257013
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18299225
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17746517
CY2020Q2 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
181184
CY2019Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
139542
CY2020Q2 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
2590078
CY2019Q2 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
2665093
us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
5918533
us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
5782665
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3501104
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3688944
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7278786
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7428472
us-gaap Share Based Compensation
ShareBasedCompensation
us-gaap Share Based Compensation
ShareBasedCompensation
10612
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
11511515
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
11101643
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
11724368
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
11992864
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
12131162
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
11737905
CY2020Q2 us-gaap Treasury Stock Value
TreasuryStockValue
5851423
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
5851423
CY2019Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
540144
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Due to the COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div> pandemic, there has been uncertainty and disruption in the global economy and financial markets. We are <div style="display: inline; font-style: italic; font: inherit;">not</div> aware of any specific event or circumstance that would require updates to our estimates or judgments or require us to revise the carrying value of our assets or liabilities as of&nbsp;the date of issuance of this Quarterly Report on Form <div style="display: inline; font-style: italic; font: inherit;">10</div>-Q. These estimates <div style="display: inline; font-style: italic; font: inherit;"> may </div>change as new events occur and additional information is obtained. Actual results could differ materially from these estimates under unanticipated conditions or assumptions.</div></div></div></div></div></div></div></div></div></div></div>
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1746000
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1746000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1746000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1746000

Files In Submission

Name View Source Status
0001437749-20-017937-index-headers.html Edgar Link pending
0001437749-20-017937-index.html Edgar Link pending
0001437749-20-017937.txt Edgar Link pending
0001437749-20-017937-xbrl.zip Edgar Link pending
ex_198177.htm Edgar Link pending
ex_198178.htm Edgar Link pending
ex_198179.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
relv-20200630.xml Edgar Link completed
relv-20200630.xsd Edgar Link pending
relv-20200630_cal.xml Edgar Link unprocessable
relv-20200630_def.xml Edgar Link unprocessable
relv-20200630_lab.xml Edgar Link unprocessable
relv-20200630_pre.xml Edgar Link unprocessable
relv20200630_10q.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending